Stock Updates

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) – Is this large market cap stock undervalued?

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), is firmly in the large market cap category with market cap of 44127.04. To be considered a large market cap stock companies have to be valued at more than $10 billion. The current price for Regeneron Pharmaceuticals, Inc. is 419.1 (with a change from open of -0.66%), this in conjunction with a target price of 467.86. Volume today has so far reached 778000, with an average volume of about 766.27. The GAP for this stock, is 0.10%.

The P/E ratio is 65.42, bringing the forward P/E to a value of 28.86. The current EPS for Regeneron Pharmaceuticals, Inc., is 6.41, with a EPS growth for this year coming to a value of 85.10%. Performance has been interesting with performance year to date coming to -22.80%.

Looking further into the growth statistics for Regeneron Pharmaceuticals, Inc., EPS is looking like it will grow 32.01% in the next year. Looking even further it is projected to be 18.62%. Quarter over quarter is 0.00% for EPS growth and for sales growth quarter over quarter it is 21.40%. Looking at past EPS growth statistics we see that for the past five years it has been 44.90%. Sales growth for the past five years has in fact been 55.00%.

Looking at the ownership, we see that the insider ownership is at 0.50% and institutional ownership is 70.90%. Shares outstanding is 105.29, while shares float is at a value of 77.55. Float short for Regeneron Pharmaceuticals, Inc. is 4.36% and the short ratio is 4.41.

In terms of debt, long term debt/equity is 0.09, while the total debt/equity comes to 0.09. The ability to meet these debts, means that the current ratio is 3.4, and the quick ratio is 3.1. The most recent gross margin is 91.40% and their operating margin is 26.70%. The profit margin is 16.00%.

Regeneron Pharmaceuticals, Inc. has seen returns on assets of 13.00%, and on investment, 16.00%. Return on equity is 20.10%. Price/Earnings to growth ratio is 3.51. Price/Sales ratio is at a value of 9.49, with Price/book ratio coming to 10.76 and Price/cash is 42.22, and finally Price/Free cash Flow is 41.93.

The simple moving averages are 2.84% and 2.43% for 20 day and 200 day simple moving average respectively. For the 52 week high and low the 52 week high is -29.28% and the 52 week low is 27.35%.

Regeneron Pharmaceuticals, Inc. has a dividend yield of *TBA, with a current price of 419.1. The ability to pay this means the payout ratio is 0.00%. This is in an industry, Biotechnology, with equally high dividends from other companies in this sector, which it is Healthcare. Regeneron Pharmaceuticals, Inc. is based in USA.

Performance in the Biotechnology industry means that Regeneron Pharmaceuticals, Inc. has seen performance for the past week of 3.09%, with performance for the month coming to 4.94%. Looking at the data for the quarter it is at a value of 20.48%, and for the half year the performance is -7.24%. Volatility for this week is 2.45% and for the month this is 2.41%.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment